LOGIN  |  REGISTER
Assertio

Syra Health to Participate in Several Upcoming Healthcare and Technology Conferences

July 03, 2024 | Last Trade: US$0.07 0.02 -21.11

CARMEL, Ind., July 3, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will participate in the following healthcare and technology conferences:

  • AI Governance Conference, July 11, in Carmel, Indiana. Syra Health utilizes AI as part of its proprietary suite of technology products. Syra Health is a sponsor of this conference and will share more about its dedication to the transparent, safe, and ethical use of AI.

  • Cric Indy's Community for Diversity, Equity & and Inclusion, Aug. 16-17. Several multinational companies will gather to discuss the event theme of "Connecting Communities and Celebrating Diversity." Syra Health is a sponsor and has also assembled a team to play cricket for the event.

  • Centene Supplier Summit, Aug. 20, in St. Louis, Missouri. Leaders and suppliers from around the country will meet to network and discuss growing business in the spirit of partnership and collaboration.

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental healthdigital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health serves everyone working in healthcare. For more information, visit www.syrahealth.com.

Contacts

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page